Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales ...
MARIETTA, Ga., April 16, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (MIMEDX or the Company) today announced that it will report its operating and financial results for the first...
Net Sales Grew 17% Year-Over-Year for the Fourth Quarter and 20% for the Full Year Fourth Quarter Net Income was $53 million, Inclusive of a $40 million One-Time Non-Cash Tax Benefit Fourth Quarter...
MARIETTA, Ga., Feb. 20, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (œMIMEDX or the œCompany) today announced that senior management will participate in the TD Cowen 44th Annual...
MARIETTA, Ga., Jan. 22, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (MIMEDX or the Company) today announced that it has enhanced its capital structure by refinancing its existing...
The FDA has highlighted deviations from current good manufacturing practice for MiMedx’s Axiofill, a placenta-based product which is under review regarding its legal classification.
MiMedx reports US FDA warning letter for Axiofill, shares drop
MARIETTA, Ga., Dec. 28, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (MIMEDX or the Company) today announced that its outstanding 95,000 shares of Series B Convertible Preferred...
MARIETTA, Ga., Nov. 02, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (œMIMEDX or the œCompany) today announced it will sponsor an Innovation Theater lunch symposium at the Symposium...
MARIETTA, Ga., Oct. 16, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (œMIMEDX or the œCompany) today announced that it will report its operating and financial results for the third...